Evaluation of the effects of duloxetine on norepinephrine transporter inhibition in healthy subjects

Trial Profile

Evaluation of the effects of duloxetine on norepinephrine transporter inhibition in healthy subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 16 Dec 2013

At a glance

  • Drugs Duloxetine (Primary) ; Escitalopram
  • Indications Anxiety disorders; Depressive disorders; Fibromyalgia; Pain; Stress incontinence
  • Focus Pharmacodynamics
  • Sponsors Eli Lilly
  • Most Recent Events

    • 11 Jun 2007 Status change from recuiting to completed
    • 12 Jan 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top